Alembic Pharma: Healthy growth story
motorolka/shutterstock.com | motorolka/shutterstock.com
Increased R&D spend should boost revenue over the long term
Alembic Pharma is attractively placed to deliver sustainable growth over the long haul, given its strong US business, focus on domestic speciality segment and commitment towards developing a long-term product pipeline through proactive investments in research and business.Investors with a three- to five-year time horizon can consider buying the stock. The stock is down 12 per cent from its Septemb...
Please Wait while comments are loading...
This article is closed for comments.
Please Email the Editor
Comments to: web.businessline@thehindu.co.in
Copyright ©2017, The Hindu Business Line